H.C. Wainwright starts Assertio at buy, calls stock underrated, overlooked
sutthirat sutthisumdang H.C. Wainwright initiated coverage of Assertio Holdings (NASDAQ:ASRT) with a buy rating, calling the stock undervalued. The investment bank said it viewed Assertio, formerly known as DepoMed, as “underrated and overlooked due to its checkered history,” which included opioid liability exposure and debt as high as $800M. ItContinue Reading